![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celoxica | LSE:CXA | London | Ordinary Share | GB00B0L9TZ33 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 1870Y Celoxica Holdings PLC 03 July 2008 CELOXICA HOLDINGS PLC ("CELOXICA" OR "THE COMPANY") Directorate Changes 3rd July 2008 - Celoxica Holdings plc (AIM: CXA) - a leading provider of accelerated, low latency computing solutions, today announces that Jack Fryer, non-executive Chairman, will be retiring from the Board with immediate effect. Non-executive Director, Jean-Marc Bouhelier, will take over the role of non-executive Chairman. Since joining the Board as non-executive Chairman in 2001, Mr. Fryer has overseen the listing of the Company on AIM in 2005, and the subsequent evolution of Celoxica. He has played an important role in the successful refocusing of the Company towards providing accelerated computing solutions to the financial services sector. The Company also announces that David Cheesman, non-executive Director, will also be retiring from the Board with immediate effect. Mr. Cheesman joined the Board in 2001 representing Advent Venture Partners, one of Celoxica's original venture capitalist investors. Following his retirement from Advent in 2007, he remained as a non-executive Director through the Company's transitional period. Lee Staines, Chief Executive of Celoxica commented, "We would like to thank both Jack and Dave for their important contributions to the evolution of Celoxica and wish them well for the future. With the redirection of the Company towards the market trading arena now complete, I am delighted that Jean-Marc has agreed to step up to the role of Chairman. His expertise in the sector has already been of great value in gaining momentum for the new Celoxica in our new target market." ENQUIRIES Celoxica Holdings plc (www.celoxica.com) Tel. +44 (0)1235 863 656 Lee Staines, CEO ICIS Tel. +44 (0) 20 7651 8688 Tom Moriarty +44 (0) 7843 260 623 Caroline Evans-Jones Arbuthnot Tel. +44 (0) 20 7012 2000 Tom Griffiths Alasdair Younie About Celoxica Celoxica is a leader in accelerated computing solutions, with a focus on low latency, high volume market data feed processing for Financial Services. Headquartered in Abingdon, Oxfordshire and New York, Celoxica is a public company quoted on AIM at the London Stock Exchange (AIM: CXA). Celoxica's solutions combine accelerated hardware, firmware, Application Programming Interfaces (APIs) and professional services to provide competitive edge to traders in today's automated and electronic trading environments. For more information, please visit the company website at www.celoxica.com This information is provided by RNS The company news service from the London Stock Exchange END BOAELLFBVDBZBBK
1 Year Celoxica Chart |
1 Month Celoxica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions